COVID-19 infection in children and adolescents

Meena Naja1, Lucy Wedderburn1,2,3, Coziana Ciurtin1

  • 1Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCLH, GOSH and Centre for Rheumatology Research, Division of Medicine, UCL, London, UK.

Insights

COVID-19 is less common in children, often presenting as mild or asymptomatic cases, leading to underdiagnosis. While severe illness and mortality are rare, a severe inflammatory syndrome can occur, requiring careful case-by-case treatment decisions.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • The COVID-19 pandemic has primarily impacted adults, with limited understanding of its effects on pediatric populations.
  • Children represent a smaller proportion of diagnosed COVID-19 cases compared to adults, potentially due to a higher prevalence of asymptomatic or mild presentations.

Purpose of the Study:

  • To review the current knowledge on the epidemiology, clinical features, and management of COVID-19 in children and adolescents.
  • To highlight the characteristics of pediatric COVID-19, including prevalence, transmission, and clinical outcomes.

Main Methods:

  • This study is a review of existing literature on COVID-19 in pediatric populations.
  • Synthesizing data on epidemiology, clinical manifestations, and treatment strategies for pediatric COVID-19.

Main Results:

  • COVID-19 prevalence is lower in children, with a significant percentage of cases being asymptomatic or mild (10-90%).
  • Common symptoms include cough, fever, and sore throat; intensive care admission and mortality are infrequent.
  • A rare but severe condition, pediatric multisystem inflammatory syndrome associated with COVID-19, has emerged.

Conclusions:

  • Paediatric COVID-19 is generally mild and often underdiagnosed, but requires monitoring for rare severe complications.
  • Supportive care is the mainstay of management; specific treatments for severe cases are considered on a case-by-case basis, ideally within clinical trials.
  • Further research is essential to fully understand the disease course and optimal treatments for COVID-19 in children.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
696
Cognitive Development During Adolescence01:18

Cognitive Development During Adolescence

During adolescence, individuals experience significant cognitive development that enhances their understanding of others' emotions and thoughts, known as cognitive empathy. This period is marked by an increased ability to adapt to others' perspectives and a more nuanced understanding of others' mental states, a skill that is foundational for social problem-solving and conflict avoidance. The development of cognitive empathy relies heavily on the theory of mind — the...
356
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147